BBIO vs SWK · rev $438.2M vs P/E 34, rev $7.81B
BridgeBio Pharma Inc (BBIO) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
BBIO currently screens at market cap $13.24B. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the BBIO and SWK stock pages for the full models.
Not investment advice.